Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer

Cancer therapy is increasingly shifting toward targeting the tumor immune microenvironment and influencing populations of tumor infiltrating lymphocytes. Breast cancer presents a unique challenge as tumors of the triple‐negative breast cancer subtype employ a multitude of immunosilencing mechanisms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bioeng Transl Med
Autors principals: Wu, Debra, Zhao, Zongmin, Kim, Jayoung, Razmi, Amaya, Wang, Lily Li‐Wen, Kapate, Neha, Gao, Yongsheng, Peng, Kevin, Ukidve, Anvay, Mitragotri, Samir
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823124/
https://ncbi.nlm.nih.gov/pubmed/33532588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/btm2.10188
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars